Bulletin
Investor Alert
×

Johnson & Johnson

NYS: JNJ

GO
/marketstate/country/us

After Hours

JNJ
/zigman2/quotes/201724570/composite

$

130.78

Change

0.00 0.00%

Volume

Volume 881,851

Sep 13, 2019, 5:40 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201724570/composite

Previous close

$ 130.43

$ 130.78

Change

+0.35 +0.27%

Day low

Day high

$129.96

$131.57

Open
Open: 131.33

52 week low

52 week high

$121.00

$148.99

Open

Market cap

$345.15B

Average volume

7.55M

P/E ratio

21.68

Rev. per Employee

$603,509

EPS

6.03

Dividend

0.95

Div yield

2.91%

Ex dividend date

8/26/19

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/jnj

MarketWatch News on JNJ

  1. Worried about the stock market? Here are easy ways to cut risk

    6:00 a.m. Sept. 14, 2019

    - Philip van Doorn

  2. Dow flat despite gains for Dow Inc., Boeing stocks

    3:55 p.m. Sept. 10, 2019

    - Automated Insights

  3. Mallinckrodt Bankruptcy Fear May Be Premature

    9:38 a.m. Sept. 6, 2019

    - Josh Nathan-Kazis

  4. How Biotech Is Targeting RNA to Cure Diseases

    8:01 a.m. Sept. 3, 2019

    - Josh Nathan-Kazis

  5. How the Johnson & Johnson Ruling Could Affect the Opioid Cases

    4:09 p.m. Aug. 30, 2019

    - Josh Nathan-Kazis

  6. Allergan Settles to Get Out of First Big Opioid Trial

    10:03 a.m. Aug. 30, 2019

    - Josh Nathan-Kazis

  7. Microsoft, Visa share losses contribute to Dow's 65-point fall

    9:45 a.m. Aug. 28, 2019

    - Automated Insights

  8. Johnson and Johnson's stock jumps 2.4% to pace Dow gainers

    9:48 a.m. Aug. 27, 2019

    - Tomi Kilgore

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/jnj

Other News on JNJ

  1. Opioid Relief Rally Is Likely to Stall

    10:00 a.m. Sept. 14, 2019

    - Charley Grant

  2. How To Save $1.5 Million Starting At 40

    8:07 a.m. Sept. 14, 2019

    - Seeking Alpha

  3. Healthcare: Still A Great Buy For Dividend Growth Investors

    3:13 a.m. Sept. 13, 2019

    - Seeking Alpha

  4. Aprea Therapeutics Files For U.S. IPO

    6:22 p.m. Sept. 12, 2019

    - Seeking Alpha

  5. Overview Of My Financial Independence Portfolio

    6:02 p.m. Sept. 12, 2019

    - Seeking Alpha

  6. 6 Stocks With Low Price-Sales Ratios

    4:20 p.m. Sept. 12, 2019

    - GuruFocus.com

  7. 9 Best Dividend Stocks to Buy for Every Investor

    9:28 a.m. Sept. 12, 2019

    - InvestorPlace.com

  8. Wall Street Breakfast: Another Wave Of Easing

    7:00 a.m. Sept. 12, 2019

    - Seeking Alpha

  9. Purdue Pharma nearing partial settlement of opioid cases

    12:57 p.m. Sept. 11, 2019

    - Seeking Alpha

  10. Lexicon (LXRX) Settles With Sanofi for $260M, Shares Rally

    9:46 a.m. Sept. 11, 2019

    - Zacks.com

  11. Theravance Announces Positive Early Data on JAK Inhibitor

    11:46 a.m. Sept. 10, 2019

    - Zacks.com

  12. 10 Healthcare Stocks to Buy Despite the Headlines

    10:55 a.m. Sept. 10, 2019

    - InvestorPlace.com

  13. Doctors Sound an Alarm Over Leg-Stent Surgery

    10:54 a.m. Sept. 10, 2019

    - Sumathi Reddy

  14. Loading more headlines...
/news/pressrelease/company/us/jnj

Press Releases on JNJ

  1. Cancer Drugs Market May Set New Growth Story

    4:33 a.m. Sept. 14, 2019

    - HTF Market Intelligence

  2. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.